EcoDrugPlus

Ensembl ID : ENSUPAG00010003168
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSUPAG00010003607
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSUPAG00010005356
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSUPAG00010006176
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSUPAG00010006680
Gene Symbol: -
Cross references: -
124 Possible Orthologues:

Ensembl ID : ENSUPAG00010006747
Gene Symbol: -
Cross references: -
230 Possible Orthologues:

Ensembl ID : ENSUPAG00010011174
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSUPAG00010012461
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSUPAG00010012689
Gene Symbol: -
Cross references: -
114 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).